Of note is the evidence that treatment of metastatic renal cell carcinoma with autologous T lymphocytes genetically retargeted against CAIX mediates clinical responses points to the further possibility of targeting pH regulators and tumor associated acidity through antigen-specific immunotherapy [108]. This evidence concerns the gene CA9 and neoplasm.